Concepedia

Bellicum Pharmaceuticals (United States)

BP

Statistics

Publications

126

Citations

11.9K

Authors

3

Location

Houston, United States

Bellicum Pharmaceuticals (United States) is a company institution in Houston, United States known for immunology, life sciences, and oncology.

HomepageROR

Top concepts

Publications

126

Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer

Leisha A. Emens, Cristina Cruz, Joseph P. Eder et al. · JAMA Oncology · 2018 · 793 citations · Full text

, , +17

IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients

Geok Choo Sim, Natalia Martín‐Orozco, Lei Jin et al. · Journal of Clinical Investigation · 2013 · 226 citations

, , +16

Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation

Xiaoou Zhou, Gianpietro Dotti, Robert A. Krance et al. · Blood · 2015 · 217 citations · Full text

, , +13

Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma

Lihua E. Budde, Carolina Berger, Yukang Lin et al. · PLoS ONE · 2013 · 189 citations · Full text

, , +17

Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models

Melinda Mata, Claudia Gerken, Phuong Nguyen et al. · Cancer Discovery · 2017 · 176 citations · Full text

, , +17

1–5 of 126

Authors

3

  1. MR
    Matthew R. Collinson-Pautz

    Bellicum Pharmaceuticals (United States), United States

    26 publications · 498 citations

    6

    h-index

  2. MT
    MyLinh T. Duong

    Bellicum Pharmaceuticals (United States), United States

    6 publications · 346 citations

    5

    h-index

  3. FG
    Fabricio G. Cabrera

    Bellicum Pharmaceuticals (United States), United States

    1 publications · 24 citations

    1

    h-index

1–3 of 3